Miao et al. demonstrate the dichotomous activities of APRIL and BAFF in MM and DLBCL, which can be safely targeted by an engineered decoy receptor designed to trap both ligands with ultra-high binding affinity. Here, TNFSF13 is linked to Miyoshi myopathy.